The effect of meal replacements therapy on blood pressure and C-reactive protein: a systematic review and meta-analysis of randomized controlled trials
Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of cardiovascular disease, there are still no comprehensive findings in this field. Therefore, we investigate the effects of total and partial MRs on BP and...
Uložené v:
| Vydané v: | Clinical hypertension Ročník 31; číslo 1; s. e17 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Korean Society of Hypertension
2025
The Korean Society of Hypertension 대한고혈압학회 |
| Predmet: | |
| ISSN: | 2056-5909, 2635-6325, 2056-5909 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of cardiovascular disease, there are still no comprehensive findings in this field. Therefore, we investigate the effects of total and partial MRs on BP and C-reactive protein (CRP) in this comprehensive study and meta-analysis. In order to identify all randomized controlled trials that investigated the effects of MRs on BP and CRP levels, a systematic search was conducted in the original databases using predefined keywords. The pooled weighted mean difference (WMD) and 95% confidence intervals (CIs) were computed using the random-effects model. Forty studies were included in this article. The findings indicated significant reductions in systolic blood pressure (SBP) (WMD, -2.51 mmHg; 95% CI, -3.48 to -1.54;
< 0.001), diastolic blood pressure (DBP) (WMD, -1.43 mmHg; 95% CI, -2.02 to -0.85;
< 0.001), and CRP (WMD, -0.50 mg/L; 95% CI, -0.89 to -0.11;
= 0.012) levels following MR consumption compared to the control group. The findings obtained from the subgroup analysis showed that MRs cause a greater reduction in SBP in people over 50 years of age, and the duration of the intervention ≤ 24 weeks. Also, the subgroup analysis shows the greater effect of DBP and CRP, respectively, in the type of intervention with total meal replacement and less equal to 50 years. In conclusion, it appears that MR, along with other lifestyle factors, can lead to significant improvements in BP and CRP. |
|---|---|
| AbstractList | Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of cardiovascular disease, there are still no comprehensive findings in this field. Therefore, we investigate the effects of total and partial MRs on BP and C-reactive protein (CRP) in this comprehensive study and metaanalysis. In order to identify all randomized controlled trials that investigated the effects of MRs on BP and CRP levels, a systematic search was conducted in the original databases using predefined keywords. The pooled weighted mean difference (WMD) and 95% confidence intervals (CIs) were computed using the random-effects model. Forty studies were included in this article. The findings indicated significant reductions in systolic blood pressure (SBP)(WMD, -2.51 mmHg; 95% CI, -3.48 to -1.54; P< 0.001), diastolic blood pressure (DBP)(WMD, -1.43 mmHg; 95% CI, -2.02 to -0.85; P< 0.001), and CRP (WMD, -0.50 mg/L; 95% CI, -0.89 to -0.11; P= 0.012) levels following MR consumption compared to the control group. The findings obtained from the subgroup analysis showed that MRs cause a greater reduction in SBP in people over 50 years of age, and the duration of the intervention [less than or equal to] 24 weeks. Also, the subgroup analysis shows the greater effect of DBP and CRP, respectively, in the type of intervention with total meal replacement and less equal to 50 years. In conclusion, it appears that MR, along with other lifestyle factors, can lead to significant improvements in BP and CRP. Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of cardiovascular disease, there are still no comprehensive findings in this field. Therefore, we investigate the effects of total and partial MRs on BP and C-reactive protein (CRP) in this comprehensive study and meta-analysis. In order to identify all randomized controlled trials that investigated the effects of MRs on BP and CRP levels, a systematic search was conducted in the original databases using predefined keywords. The pooled weighted mean difference (WMD) and 95% confidence intervals (CIs) were computed using the random-effects model. Forty studies were included in this article. The findings indicated significant reductions in systolic blood pressure (SBP) (WMD, −2.51 mmHg; 95% CI, −3.48 to −1.54; P < 0.001), diastolic blood pressure (DBP) (WMD, −1.43 mmHg; 95% CI, −2.02 to −0.85; P < 0.001), and CRP (WMD, −0.50 mg/L; 95% CI, −0.89 to −0.11; P = 0.012) levels following MR consumption compared to the control group. The findings obtained from the subgroup analysis showed that MRs cause a greater reduction in SBP in people over 50 years of age, and the duration of the intervention ≤ 24 weeks. Also, the subgroup analysis shows the greater effect of DBP and CRP, respectively, in the type of intervention with total meal replacement and less equal to 50 years. In conclusion, it appears that MR, along with other lifestyle factors, can lead to significant improvements in BP and CRP. KCI Citation Count: 0 Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of cardiovascular disease, there are still no comprehensive findings in this field. Therefore, we investigate the effects of total and partial MRs on BP and C-reactive protein (CRP) in this comprehensive study and metaanalysis. In order to identify all randomized controlled trials that investigated the effects of MRs on BP and CRP levels, a systematic search was conducted in the original databases using predefined keywords. The pooled weighted mean difference (WMD) and 95% confidence intervals (CIs) were computed using the random-effects model. Forty studies were included in this article. The findings indicated significant reductions in systolic blood pressure (SBP)(WMD, -2.51 mmHg; 95% CI, -3.48 to -1.54; P< 0.001), diastolic blood pressure (DBP)(WMD, -1.43 mmHg; 95% CI, -2.02 to -0.85; P< 0.001), and CRP (WMD, -0.50 mg/L; 95% CI, -0.89 to -0.11; P= 0.012) levels following MR consumption compared to the control group. The findings obtained from the subgroup analysis showed that MRs cause a greater reduction in SBP in people over 50 years of age, and the duration of the intervention [less than or equal to] 24 weeks. Also, the subgroup analysis shows the greater effect of DBP and CRP, respectively, in the type of intervention with total meal replacement and less equal to 50 years. In conclusion, it appears that MR, along with other lifestyle factors, can lead to significant improvements in BP and CRP. Keywords: Meal replacements; Lifestyle; Blood pressure; Inflammation; Meta-analysis Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of cardiovascular disease, there are still no comprehensive findings in this field. Therefore, we investigate the effects of total and partial MRs on BP and C-reactive protein (CRP) in this comprehensive study and meta-analysis. In order to identify all randomized controlled trials that investigated the effects of MRs on BP and CRP levels, a systematic search was conducted in the original databases using predefined keywords. The pooled weighted mean difference (WMD) and 95% confidence intervals (CIs) were computed using the random-effects model. Forty studies were included in this article. The findings indicated significant reductions in systolic blood pressure (SBP) (WMD, -2.51 mmHg; 95% CI, -3.48 to -1.54; P < 0.001), diastolic blood pressure (DBP) (WMD, -1.43 mmHg; 95% CI, -2.02 to -0.85; P < 0.001), and CRP (WMD, -0.50 mg/L; 95% CI, -0.89 to -0.11; P = 0.012) levels following MR consumption compared to the control group. The findings obtained from the subgroup analysis showed that MRs cause a greater reduction in SBP in people over 50 years of age, and the duration of the intervention ≤ 24 weeks. Also, the subgroup analysis shows the greater effect of DBP and CRP, respectively, in the type of intervention with total meal replacement and less equal to 50 years. In conclusion, it appears that MR, along with other lifestyle factors, can lead to significant improvements in BP and CRP.Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of cardiovascular disease, there are still no comprehensive findings in this field. Therefore, we investigate the effects of total and partial MRs on BP and C-reactive protein (CRP) in this comprehensive study and meta-analysis. In order to identify all randomized controlled trials that investigated the effects of MRs on BP and CRP levels, a systematic search was conducted in the original databases using predefined keywords. The pooled weighted mean difference (WMD) and 95% confidence intervals (CIs) were computed using the random-effects model. Forty studies were included in this article. The findings indicated significant reductions in systolic blood pressure (SBP) (WMD, -2.51 mmHg; 95% CI, -3.48 to -1.54; P < 0.001), diastolic blood pressure (DBP) (WMD, -1.43 mmHg; 95% CI, -2.02 to -0.85; P < 0.001), and CRP (WMD, -0.50 mg/L; 95% CI, -0.89 to -0.11; P = 0.012) levels following MR consumption compared to the control group. The findings obtained from the subgroup analysis showed that MRs cause a greater reduction in SBP in people over 50 years of age, and the duration of the intervention ≤ 24 weeks. Also, the subgroup analysis shows the greater effect of DBP and CRP, respectively, in the type of intervention with total meal replacement and less equal to 50 years. In conclusion, it appears that MR, along with other lifestyle factors, can lead to significant improvements in BP and CRP. Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of cardiovascular disease, there are still no comprehensive findings in this field. Therefore, we investigate the effects of total and partial MRs on BP and C-reactive protein (CRP) in this comprehensive study and meta-analysis. In order to identify all randomized controlled trials that investigated the effects of MRs on BP and CRP levels, a systematic search was conducted in the original databases using predefined keywords. The pooled weighted mean difference (WMD) and 95% confidence intervals (CIs) were computed using the random-effects model. Forty studies were included in this article. The findings indicated significant reductions in systolic blood pressure (SBP) (WMD, -2.51 mmHg; 95% CI, -3.48 to -1.54; < 0.001), diastolic blood pressure (DBP) (WMD, -1.43 mmHg; 95% CI, -2.02 to -0.85; < 0.001), and CRP (WMD, -0.50 mg/L; 95% CI, -0.89 to -0.11; = 0.012) levels following MR consumption compared to the control group. The findings obtained from the subgroup analysis showed that MRs cause a greater reduction in SBP in people over 50 years of age, and the duration of the intervention ≤ 24 weeks. Also, the subgroup analysis shows the greater effect of DBP and CRP, respectively, in the type of intervention with total meal replacement and less equal to 50 years. In conclusion, it appears that MR, along with other lifestyle factors, can lead to significant improvements in BP and CRP. Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of cardiovascular disease, there are still no comprehensive findings in this field. Therefore, we investigate the effects of total and partial MRs on BP and C-reactive protein (CRP) in this comprehensive study and meta-analysis. In order to identify all randomized controlled trials that investigated the effects of MRs on BP and CRP levels, a systematic search was conducted in the original databases using predefined keywords. The pooled weighted mean difference (WMD) and 95% confidence intervals (CIs) were computed using the random-effects model. Forty studies were included in this article. The findings indicated significant reductions in systolic blood pressure (SBP) (WMD, −2.51 mmHg; 95% CI, −3.48 to −1.54; P < 0.001), diastolic blood pressure (DBP) (WMD, −1.43 mmHg; 95% CI, −2.02 to −0.85; P < 0.001), and CRP (WMD, −0.50 mg/L; 95% CI, −0.89 to −0.11; P = 0.012) levels following MR consumption compared to the control group. The findings obtained from the subgroup analysis showed that MRs cause a greater reduction in SBP in people over 50 years of age, and the duration of the intervention ≤ 24 weeks. Also, the subgroup analysis shows the greater effect of DBP and CRP, respectively, in the type of intervention with total meal replacement and less equal to 50 years. In conclusion, it appears that MR, along with other lifestyle factors, can lead to significant improvements in BP and CRP. |
| Audience | Academic |
| Author | Prabahar, Kousalya Fotros, Danial Fatahi, Somaye Guimarães, Nathalia Sernizon Rohani, Pejman Sohouli, Mohammad Hassan |
| AuthorAffiliation | 3 Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia 2 Pediatric Gastroenterology and Hepatology Research Center, Pediatrics Centre of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran 1 Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran 4 Department of Nutrition, School of Nursing, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil |
| AuthorAffiliation_xml | – name: 4 Department of Nutrition, School of Nursing, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil – name: 1 Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran – name: 2 Pediatric Gastroenterology and Hepatology Research Center, Pediatrics Centre of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran – name: 3 Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia |
| Author_xml | – sequence: 1 givenname: Danial orcidid: 0000-0001-7028-1934 surname: Fotros fullname: Fotros, Danial organization: Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 2 givenname: Pejman orcidid: 0009-0002-9712-5581 surname: Rohani fullname: Rohani, Pejman organization: Pediatric Gastroenterology and Hepatology Research Center, Pediatrics Centre of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran – sequence: 3 givenname: Kousalya orcidid: 0000-0001-8224-4276 surname: Prabahar fullname: Prabahar, Kousalya organization: Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia – sequence: 4 givenname: Somaye orcidid: 0000-0002-0834-9894 surname: Fatahi fullname: Fatahi, Somaye organization: Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 5 givenname: Mohammad Hassan orcidid: 0000-0002-6723-7112 surname: Sohouli fullname: Sohouli, Mohammad Hassan organization: Pediatric Gastroenterology and Hepatology Research Center, Pediatrics Centre of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran – sequence: 6 givenname: Nathalia Sernizon orcidid: 0000-0002-7793-0623 surname: Guimarães fullname: Guimarães, Nathalia Sernizon organization: Department of Nutrition, School of Nursing, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40336505$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003200329$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNptkm2LEzEQxxc58c56b30pAUFE2JqHTXbXN1KKDwcHgtTXIZudvY2XTWqSVuoX8euatud5BQlkhslv_sNM5mlx5ryDonhO8JyLSrzV45xiyueMzIHUj4oLirkoeYvbswf-eXEZ43eMMeG8bbF4UpxXmDHBMb8ofq9GQDAMoBPyA5pAWRRgbZWGCVyKKI0Q1HqHvEOd9b5H6wAxbgIg5Xq0LAMoncwWctwnMO4dUijuYoJJJaOz1tbAzwM7QVKlcsruoon7YiFH_WR-QY-0dyl4a7ObglE2PiseD9nA5Z2dFd8-flgtP5fXXz5dLRfXpa4aksquoVgMXddRpnuqlBBa9YQ2uq017TEQhqFiVNQ1EN43ApqasrojXdfUUFHMZsWbo64Lg7zVRnplDvbGy9sgF19XV5LgGrc15hl-f4TXm26CXucBBWXlOphJhd0h9fTFmTELbSXJn8E5plnh9Z1C8D82EJOcTNRgrXLgN1EyikmFBaVNRl8e0RtlQRo3-Cyp97hcNIIxxut8zYr5f6h8ephMnioMJsdPEl49SBjzf6cxertJxrt4Cr542Ox9l393519pHXyMAYZ7hGC530-pR7nfT8mIzPvJ_gDxU9hL |
| Cites_doi | 10.1111/j.1743-6109.2011.02417.x 10.1038/oby.2000.48 10.1017/S0007114512001328 10.1016/j.phrs.2017.11.003 10.1111/dom.15392 10.1038/ijo.2013.43 10.1186/s12986-023-00740-5 10.1038/sj.ijo.0803039 10.1016/j.ehj.2014.11.005 10.1001/archinte.167.1.31 10.3389/fimmu.2018.01302 10.2337/dc20-0129 10.3390/nu12072022 10.1177/0145721707312463 10.1016/j.exger.2009.07.007 10.1016/j.nutres.2013.07.002 10.1186/1475-2891-9-11 10.1016/S0140-6736(17)33102-1 10.2337/dc18-2270 10.1016/j.jand.2021.05.001 10.1136/bmj.315.7109.629 10.1136/bmj.38833.411204.80 10.1002/9781119536604.ch8 10.1038/s41387-018-0034-0 10.1186/2046-4053-4-1 10.3390/nu11091970 10.1016/j.jacc.2020.11.010 10.1038/ijo.2014.216 10.1186/1475-2891-11-44 10.1016/S0140-6736(18)32225-6 10.1016/j.orcp.2012.03.002 10.2337/dc17-0303 10.1016/j.amjcard.2023.03.025 10.1002/osp4.312 10.3945/an.116.013052 10.1111/obr.12816 10.2337/dc13-2900 10.1136/bmj.k3760 10.1016/S2213-8587(20)30117-0 10.1136/bmjdrc-2019-001012 10.1016/S0140-6736(20)30925-9 10.1016/S0140-6736(18)32203-7 10.1016/S0140-6736(14)60685-1 10.3390/nu14235054 10.1017/S0007114514001123 10.1080/09637480903136667 10.1038/s41366-021-00915-1 10.1161/01.HYP.0000094221.86888.AE 10.1161/circ.109.21.2475 10.3390/nu12040976 10.1002/oby.22359 10.3390/nu11010165 10.1155/2018/2837367 10.1016/j.jff.2015.01.040 10.1186/1743-7075-8-64 10.1007/s12603-010-0100-3 10.1038/sj.ijo.0802258 10.1016/S2213-8587(19)30068-3 10.1161/HYPERTENSIONAHA.119.14240 10.1136/bmjdrc-2016-000384 10.1016/S0140-6736(21)01330-1 10.1186/1471-2288-5-13 10.1002/dmrr.1097 10.1016/j.jada.2011.03.013 10.1136/bmj.327.7414.557 10.1017/S0007114517001295 10.1080/09637486.2018.1537363 10.1038/s41430-020-00783-4 |
| ContentType | Journal Article |
| Copyright | Copyright © 2025 The Korean Society of Hypertension. COPYRIGHT 2025 Korean Society of Hypertension Copyright © 2025 The Korean Society of Hypertension 2025 The Korean Society of Hypertension |
| Copyright_xml | – notice: Copyright © 2025 The Korean Society of Hypertension. – notice: COPYRIGHT 2025 Korean Society of Hypertension – notice: Copyright © 2025 The Korean Society of Hypertension 2025 The Korean Society of Hypertension |
| DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
| DOI | 10.5646/ch.2025.31.e17 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2056-5909 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_10709705 PMC12055502 A863335733 40336505 10_5646_ch_2025_31_e17 |
| Genre | Journal Article Review |
| GroupedDBID | 0R~ 5-W 5VS 8JR AAFWJ AAYXX ACGFS ADBBV ADRAZ ADUKV AFPKN AHBYD AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS ASPBG BAWUL BCNDV BFQNJ BMC C6C CITATION DIK EBS EF. EJD GROUPED_DOAJ H13 HYE IAO IHR IHW ITC KQ8 M48 M~E OK1 PGMZT RBZ ROL RPM RSV SOJ NPM 7X8 5PM ACYCR |
| ID | FETCH-LOGICAL-c481t-b8206fbbb23cd2aa66cad128c97c2d0e130e432677e15d86e87237b1bb87e4203 |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001484316300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2056-5909 2635-6325 |
| IngestDate | Thu Jun 19 03:20:30 EDT 2025 Tue Sep 30 17:03:11 EDT 2025 Fri Sep 05 17:13:50 EDT 2025 Thu Nov 20 00:32:40 EST 2025 Tue Nov 18 03:51:48 EST 2025 Tue Nov 18 02:11:00 EST 2025 Sat May 10 01:41:17 EDT 2025 Sat Nov 29 07:56:26 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Lifestyle Blood pressure Inflammation Meal replacements Meta-analysis |
| Language | English |
| License | Copyright © 2025 The Korean Society of Hypertension. It is identical to the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/). |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c481t-b8206fbbb23cd2aa66cad128c97c2d0e130e432677e15d86e87237b1bb87e4203 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 https://clinicalhypertension.org/DOIx.php?id=10.5646/ch.2025.31.e17 |
| ORCID | 0000-0001-8224-4276 0000-0001-7028-1934 0000-0002-0834-9894 0000-0002-6723-7112 0009-0002-9712-5581 0000-0002-7793-0623 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC12055502 |
| PMID | 40336505 |
| PQID | 3201406228 |
| PQPubID | 23479 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10709705 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12055502 proquest_miscellaneous_3201406228 gale_infotracmisc_A863335733 gale_infotracacademiconefile_A863335733 gale_healthsolutions_A863335733 pubmed_primary_40336505 crossref_primary_10_5646_ch_2025_31_e17 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-00-00 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – year: 2025 text: 2025-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Clinical hypertension |
| PublicationTitleAlternate | Clin Hypertens |
| PublicationYear | 2025 |
| Publisher | Korean Society of Hypertension The Korean Society of Hypertension 대한고혈압학회 |
| Publisher_xml | – name: Korean Society of Hypertension – name: The Korean Society of Hypertension – name: 대한고혈압학회 |
| References | Shirai (10.5646/ch.2025.31.e17_ref29) 2013; 7 Lean (10.5646/ch.2025.31.e17_ref24) 2018; 391 Miller (10.5646/ch.2025.31.e17_ref71) 2010; 14 Röhling (10.5646/ch.2025.31.e17_ref42) 2020; 12 Metzner (10.5646/ch.2025.31.e17_ref27) 2011; 8 Flechtner-Mors (10.5646/ch.2025.31.e17_ref50) 2010; 26 Luan (10.5646/ch.2025.31.e17_ref63) 2018; 9 Shih (10.5646/ch.2025.31.e17_ref57) 2019; 11 Astrup (10.5646/ch.2025.31.e17_ref10) 2015; 39 Truby (10.5646/ch.2025.31.e17_ref31) 2006; 332 Brown (10.5646/ch.2025.31.e17_ref35) 2020; 8 Astbury (10.5646/ch.2025.31.e17_ref40) 2021; 45 GBD 2017 Causes of Death Collaborators (10.5646/ch.2025.31.e17_ref4) 2018; 392 Siener (10.5646/ch.2025.31.e17_ref41) 2022; 14 Stenvers (10.5646/ch.2025.31.e17_ref53) 2014; 112 Roth (10.5646/ch.2025.31.e17_ref1) 2020; 76 Zhong (10.5646/ch.2025.31.e17_ref52) 2023; 20 Shrivastava (10.5646/ch.2025.31.e17_ref64) 2015; 67 Rock (10.5646/ch.2025.31.e17_ref26) 2014; 37 Halle (10.5646/ch.2025.31.e17_ref33) 2021; 75 Flechtner-Mors (10.5646/ch.2025.31.e17_ref47) 2000; 8 Wadden (10.5646/ch.2025.31.e17_ref37) 2019; 27 Sun (10.5646/ch.2025.31.e17_ref51) 2008; 17 Grillo (10.5646/ch.2025.31.e17_ref69) 2019; 11 Kuriyan (10.5646/ch.2025.31.e17_ref70) 2017; 26 Tovar (10.5646/ch.2025.31.e17_ref72) 2012; 11 Chaiyasoot (10.5646/ch.2025.31.e17_ref39) 2018; 8 Clifton (10.5646/ch.2025.31.e17_ref48) 2005; 29 Rapsomaniki (10.5646/ch.2025.31.e17_ref7) 2014; 383 Sawashita (10.5646/ch.2025.31.e17_ref58) 2009; 44 Fuchs (10.5646/ch.2025.31.e17_ref3) 2020; 75 GBD 2019 Diseases and Injuries Collaborators (10.5646/ch.2025.31.e17_ref2) 2020; 396 Astbury (10.5646/ch.2025.31.e17_ref14) 2019; 20 Shikany (10.5646/ch.2025.31.e17_ref46) 2013; 37 Neter (10.5646/ch.2025.31.e17_ref66) 2003; 42 Ard (10.5646/ch.2025.31.e17_ref34) 2024; 26 Kempf (10.5646/ch.2025.31.e17_ref55) 2017; 40 Ashley (10.5646/ch.2025.31.e17_ref59) 2001; 9 Chee (10.5646/ch.2025.31.e17_ref61) 2017; 5 Higgins (10.5646/ch.2025.31.e17_ref17) 2019; 2019 Arterburn (10.5646/ch.2025.31.e17_ref43) 2018; 5 Min (10.5646/ch.2025.31.e17_ref67) 2021; 121 Lean (10.5646/ch.2025.31.e17_ref60) 2019; 7 Selvin (10.5646/ch.2025.31.e17_ref68) 2007; 167 Lee (10.5646/ch.2025.31.e17_ref44) 2015; 19 Santos (10.5646/ch.2025.31.e17_ref73) 2013; 33 Willerson (10.5646/ch.2025.31.e17_ref9) 2004; 109 10.5646/ch.2025.31.e17_ref19 Guo (10.5646/ch.2025.31.e17_ref28) 2018; 2018 Gulsin (10.5646/ch.2025.31.e17_ref56) 2020; 43 Schwingshackl (10.5646/ch.2025.31.e17_ref18) 2016; 7 Siebenhofer (10.5646/ch.2025.31.e17_ref65) 2021; 1 Cheskin (10.5646/ch.2025.31.e17_ref32) 2008; 34 Hozo (10.5646/ch.2025.31.e17_ref20) 2005; 5 Gulati (10.5646/ch.2025.31.e17_ref54) 2017; 117 Egger (10.5646/ch.2025.31.e17_ref22) 1997; 315 Davis (10.5646/ch.2025.31.e17_ref12) 2010; 9 Noronha (10.5646/ch.2025.31.e17_ref13) 2019; 42 Taheri (10.5646/ch.2025.31.e17_ref38) 2020; 8 GBD 2017 Risk Factor Collaborators (10.5646/ch.2025.31.e17_ref5) 2018; 392 Armborst (10.5646/ch.2025.31.e17_ref25) 2019; 70 Khoo (10.5646/ch.2025.31.e17_ref49) 2011; 8 Heymsfield (10.5646/ch.2025.31.e17_ref11) 2003; 27 Moher (10.5646/ch.2025.31.e17_ref16) 2015; 4 Kjeldsen (10.5646/ch.2025.31.e17_ref62) 2018; 129 Burger (10.5646/ch.2025.31.e17_ref8) 2023; 197 Kreider (10.5646/ch.2025.31.e17_ref23) 2011; 111 Astbury (10.5646/ch.2025.31.e17_ref30) 2018; 362 Xu (10.5646/ch.2025.31.e17_ref36) 2013; 109 López-Gómez (10.5646/ch.2025.31.e17_ref15) 2020; 12 NCD Risk Factor Collaboration (NCD-RisC) (10.5646/ch.2025.31.e17_ref6) 2021; 398 Tsai (10.5646/ch.2025.31.e17_ref45) 2009; 60 Higgins (10.5646/ch.2025.31.e17_ref21) 2003; 327 |
| References_xml | – volume: 8 start-page: 2868 year: 2011 ident: 10.5646/ch.2025.31.e17_ref49 publication-title: J Sex Med doi: 10.1111/j.1743-6109.2011.02417.x – volume: 17 start-page: 514 year: 2008 ident: 10.5646/ch.2025.31.e17_ref51 publication-title: Asia Pac J Clin Nutr – volume: 1 start-page: CD007654 year: 2021 ident: 10.5646/ch.2025.31.e17_ref65 publication-title: Cochrane Database Syst Rev – volume: 8 start-page: 399 year: 2000 ident: 10.5646/ch.2025.31.e17_ref47 publication-title: Obes Res doi: 10.1038/oby.2000.48 – volume: 109 start-page: 487 year: 2013 ident: 10.5646/ch.2025.31.e17_ref36 publication-title: Br J Nutr doi: 10.1017/S0007114512001328 – volume: 129 start-page: 95 year: 2018 ident: 10.5646/ch.2025.31.e17_ref62 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2017.11.003 – volume: 26 start-page: 950 year: 2024 ident: 10.5646/ch.2025.31.e17_ref34 publication-title: Diabetes Obes Metab doi: 10.1111/dom.15392 – volume: 37 start-page: 1571 year: 2013 ident: 10.5646/ch.2025.31.e17_ref46 publication-title: Int J Obes doi: 10.1038/ijo.2013.43 – volume: 20 start-page: 18 year: 2023 ident: 10.5646/ch.2025.31.e17_ref52 publication-title: Nutr Metab (Lond) doi: 10.1186/s12986-023-00740-5 – volume: 29 start-page: 1445 year: 2005 ident: 10.5646/ch.2025.31.e17_ref48 publication-title: Int J Obes doi: 10.1038/sj.ijo.0803039 – volume: 67 start-page: 89 year: 2015 ident: 10.5646/ch.2025.31.e17_ref64 publication-title: Egypt Heart J doi: 10.1016/j.ehj.2014.11.005 – volume: 167 start-page: 31 year: 2007 ident: 10.5646/ch.2025.31.e17_ref68 publication-title: Arch Intern Med doi: 10.1001/archinte.167.1.31 – volume: 9 start-page: 1302 year: 2018 ident: 10.5646/ch.2025.31.e17_ref63 publication-title: Front Immunol doi: 10.3389/fimmu.2018.01302 – volume: 43 start-page: 1300 year: 2020 ident: 10.5646/ch.2025.31.e17_ref56 publication-title: Diabetes Care doi: 10.2337/dc20-0129 – volume: 12 start-page: 2022 year: 2020 ident: 10.5646/ch.2025.31.e17_ref42 publication-title: Nutrients doi: 10.3390/nu12072022 – volume: 34 start-page: 118 year: 2008 ident: 10.5646/ch.2025.31.e17_ref32 publication-title: Diabetes Educ doi: 10.1177/0145721707312463 – volume: 44 start-page: 666 year: 2009 ident: 10.5646/ch.2025.31.e17_ref58 publication-title: Exp Gerontol doi: 10.1016/j.exger.2009.07.007 – volume: 33 start-page: 687 year: 2013 ident: 10.5646/ch.2025.31.e17_ref73 publication-title: Nutr Res doi: 10.1016/j.nutres.2013.07.002 – volume: 9 start-page: 11 year: 2010 ident: 10.5646/ch.2025.31.e17_ref12 publication-title: Nutr J doi: 10.1186/1475-2891-9-11 – volume: 391 start-page: 541 year: 2018 ident: 10.5646/ch.2025.31.e17_ref24 publication-title: Lancet doi: 10.1016/S0140-6736(17)33102-1 – volume: 42 start-page: 767 year: 2019 ident: 10.5646/ch.2025.31.e17_ref13 publication-title: Diabetes Care doi: 10.2337/dc18-2270 – volume: 121 start-page: 1551 year: 2021 ident: 10.5646/ch.2025.31.e17_ref67 publication-title: J Acad Nutr Diet doi: 10.1016/j.jand.2021.05.001 – volume: 315 start-page: 629 year: 1997 ident: 10.5646/ch.2025.31.e17_ref22 publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – volume: 332 start-page: 1309 year: 2006 ident: 10.5646/ch.2025.31.e17_ref31 publication-title: BMJ doi: 10.1136/bmj.38833.411204.80 – volume: 2019 start-page: 205 year: 2019 ident: 10.5646/ch.2025.31.e17_ref17 publication-title: Cochrane handbook for systematic reviews of interventions doi: 10.1002/9781119536604.ch8 – volume: 8 start-page: 23 year: 2018 ident: 10.5646/ch.2025.31.e17_ref39 publication-title: Nutr Diabetes doi: 10.1038/s41387-018-0034-0 – volume: 4 start-page: 1 year: 2015 ident: 10.5646/ch.2025.31.e17_ref16 publication-title: Syst Rev doi: 10.1186/2046-4053-4-1 – volume: 11 start-page: 1970 year: 2019 ident: 10.5646/ch.2025.31.e17_ref69 publication-title: Nutrients doi: 10.3390/nu11091970 – volume: 76 start-page: 2982 year: 2020 ident: 10.5646/ch.2025.31.e17_ref1 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.11.010 – volume: 39 start-page: 721 year: 2015 ident: 10.5646/ch.2025.31.e17_ref10 publication-title: Int J Obes doi: 10.1038/ijo.2014.216 – volume: 11 start-page: 44 year: 2012 ident: 10.5646/ch.2025.31.e17_ref72 publication-title: Nutr J doi: 10.1186/1475-2891-11-44 – volume: 392 start-page: 1923 year: 2018 ident: 10.5646/ch.2025.31.e17_ref5 publication-title: Lancet doi: 10.1016/S0140-6736(18)32225-6 – volume: 7 start-page: e43 year: 2013 ident: 10.5646/ch.2025.31.e17_ref29 publication-title: Obes Res Clin Pract doi: 10.1016/j.orcp.2012.03.002 – volume: 40 start-page: 863 year: 2017 ident: 10.5646/ch.2025.31.e17_ref55 publication-title: Diabetes Care doi: 10.2337/dc17-0303 – volume: 197 start-page: 13 year: 2023 ident: 10.5646/ch.2025.31.e17_ref8 publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2023.03.025 – volume: 5 start-page: 3 year: 2018 ident: 10.5646/ch.2025.31.e17_ref43 publication-title: Obes Sci Pract doi: 10.1002/osp4.312 – volume: 7 start-page: 994 year: 2016 ident: 10.5646/ch.2025.31.e17_ref18 publication-title: Adv Nutr doi: 10.3945/an.116.013052 – volume: 26 start-page: 1055 year: 2017 ident: 10.5646/ch.2025.31.e17_ref70 publication-title: Asia Pac J Clin Nutr – volume: 20 start-page: 569 year: 2019 ident: 10.5646/ch.2025.31.e17_ref14 publication-title: Obes Rev doi: 10.1111/obr.12816 – ident: 10.5646/ch.2025.31.e17_ref19 – volume: 37 start-page: 1573 year: 2014 ident: 10.5646/ch.2025.31.e17_ref26 publication-title: Diabetes Care doi: 10.2337/dc13-2900 – volume: 362 start-page: k3760 year: 2018 ident: 10.5646/ch.2025.31.e17_ref30 publication-title: BMJ doi: 10.1136/bmj.k3760 – volume: 8 start-page: 477 year: 2020 ident: 10.5646/ch.2025.31.e17_ref38 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(20)30117-0 – volume: 8 start-page: e001012 year: 2020 ident: 10.5646/ch.2025.31.e17_ref35 publication-title: BMJ Open Diabetes Res Care doi: 10.1136/bmjdrc-2019-001012 – volume: 9 start-page: 312S issue: Suppl 4 year: 2001 ident: 10.5646/ch.2025.31.e17_ref59 publication-title: Obes Res – volume: 396 start-page: 1204 year: 2020 ident: 10.5646/ch.2025.31.e17_ref2 publication-title: Lancet doi: 10.1016/S0140-6736(20)30925-9 – volume: 392 start-page: 1736 year: 2018 ident: 10.5646/ch.2025.31.e17_ref4 publication-title: Lancet doi: 10.1016/S0140-6736(18)32203-7 – volume: 383 start-page: 1899 year: 2014 ident: 10.5646/ch.2025.31.e17_ref7 publication-title: Lancet doi: 10.1016/S0140-6736(14)60685-1 – volume: 14 start-page: 5054 year: 2022 ident: 10.5646/ch.2025.31.e17_ref41 publication-title: Nutrients doi: 10.3390/nu14235054 – volume: 112 start-page: 504 year: 2014 ident: 10.5646/ch.2025.31.e17_ref53 publication-title: Br J Nutr doi: 10.1017/S0007114514001123 – volume: 60 start-page: 151 issue: Suppl 6 year: 2009 ident: 10.5646/ch.2025.31.e17_ref45 publication-title: Int J Food Sci Nutr doi: 10.1080/09637480903136667 – volume: 45 start-page: 2432 year: 2021 ident: 10.5646/ch.2025.31.e17_ref40 publication-title: Int J Obes doi: 10.1038/s41366-021-00915-1 – volume: 42 start-page: 878 year: 2003 ident: 10.5646/ch.2025.31.e17_ref66 publication-title: Hypertension doi: 10.1161/01.HYP.0000094221.86888.AE – volume: 109 start-page: II2 issue: 21 year: 2004 ident: 10.5646/ch.2025.31.e17_ref9 publication-title: Circulation doi: 10.1161/circ.109.21.2475 – volume: 12 start-page: 976 year: 2020 ident: 10.5646/ch.2025.31.e17_ref15 publication-title: Nutrients doi: 10.3390/nu12040976 – volume: 27 start-page: 75 year: 2019 ident: 10.5646/ch.2025.31.e17_ref37 publication-title: Obesity (Silver Spring) doi: 10.1002/oby.22359 – volume: 11 start-page: 165 year: 2019 ident: 10.5646/ch.2025.31.e17_ref57 publication-title: Nutrients doi: 10.3390/nu11010165 – volume: 2018 start-page: 2837367 year: 2018 ident: 10.5646/ch.2025.31.e17_ref28 publication-title: J Obes doi: 10.1155/2018/2837367 – volume: 19 start-page: 929 year: 2015 ident: 10.5646/ch.2025.31.e17_ref44 publication-title: J Funct Foods doi: 10.1016/j.jff.2015.01.040 – volume: 8 start-page: 64 year: 2011 ident: 10.5646/ch.2025.31.e17_ref27 publication-title: Nutr Metab (Lond) doi: 10.1186/1743-7075-8-64 – volume: 14 start-page: 461 year: 2010 ident: 10.5646/ch.2025.31.e17_ref71 publication-title: J Nutr Health Aging doi: 10.1007/s12603-010-0100-3 – volume: 27 start-page: 537 year: 2003 ident: 10.5646/ch.2025.31.e17_ref11 publication-title: Int J Obes doi: 10.1038/sj.ijo.0802258 – volume: 7 start-page: 344 year: 2019 ident: 10.5646/ch.2025.31.e17_ref60 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(19)30068-3 – volume: 75 start-page: 285 year: 2020 ident: 10.5646/ch.2025.31.e17_ref3 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.119.14240 – volume: 5 start-page: e000384 year: 2017 ident: 10.5646/ch.2025.31.e17_ref61 publication-title: BMJ Open Diabetes Res Care doi: 10.1136/bmjdrc-2016-000384 – volume: 398 start-page: 957 year: 2021 ident: 10.5646/ch.2025.31.e17_ref6 publication-title: Lancet doi: 10.1016/S0140-6736(21)01330-1 – volume: 5 start-page: 13 year: 2005 ident: 10.5646/ch.2025.31.e17_ref20 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-5-13 – volume: 26 start-page: 393 year: 2010 ident: 10.5646/ch.2025.31.e17_ref50 publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.1097 – volume: 111 start-page: 828 year: 2011 ident: 10.5646/ch.2025.31.e17_ref23 publication-title: J Am Diet Assoc doi: 10.1016/j.jada.2011.03.013 – volume: 327 start-page: 557 year: 2003 ident: 10.5646/ch.2025.31.e17_ref21 publication-title: BMJ doi: 10.1136/bmj.327.7414.557 – volume: 117 start-page: 1531 year: 2017 ident: 10.5646/ch.2025.31.e17_ref54 publication-title: Br J Nutr doi: 10.1017/S0007114517001295 – volume: 70 start-page: 453 year: 2019 ident: 10.5646/ch.2025.31.e17_ref25 publication-title: Int J Food Sci Nutr doi: 10.1080/09637486.2018.1537363 – volume: 75 start-page: 661 year: 2021 ident: 10.5646/ch.2025.31.e17_ref33 publication-title: Eur J Clin Nutr doi: 10.1038/s41430-020-00783-4 |
| SSID | ssj0001559906 ssib042018900 |
| Score | 2.2786555 |
| SecondaryResourceType | review_article |
| Snippet | Although some evidence shows the beneficial effects of meal replacement (MR) on blood pressure (BP) and inflammation as one of the main factors of... |
| SourceID | nrf pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | e17 |
| SubjectTerms | Analysis Blood pressure C-reactive protein Cardiovascular diseases Inflammation Review Type 2 diabetes 내과학 |
| Title | The effect of meal replacements therapy on blood pressure and C-reactive protein: a systematic review and meta-analysis of randomized controlled trials |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40336505 https://www.proquest.com/docview/3201406228 https://pubmed.ncbi.nlm.nih.gov/PMC12055502 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003200329 |
| Volume | 31 |
| WOSCitedRecordID | wos001484316300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Clinical Hypertension, 2025, 31(0) |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 2056-5909 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001559906 issn: 2056-5909 databaseCode: RBZ dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2056-5909 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001559906 issn: 2056-5909 databaseCode: M~E dateStart: 20140101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 2056-5909 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001559906 issn: 2056-5909 databaseCode: RSV dateStart: 20141201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELbaghAXxD8LpRiBxGGVkthJ7OVWVVQgRFVBkXqzHMdhl3aTandbtRx4Dd6DJ2TGzs9m1UM5cMlGiWM7O1_sGfubGUJe63zEmGVZUJjCBLFOw0ByUwRFmmcpK2RYRJlLNiH29-XR0ehgbe1P4wtzfiLKUl5cjE7_q6jhGggbXWf_QdxtpXABzkHocASxw_HagvcsDb937iL3O-qV92bzHleXuEvgWOtDR4Vt9hF2A9Ai3Rg4dCEcJqV3h16N-OyJxFO70IFeimsCM19eTSc_bd6Q4E_g1KUGmS_rwbuNQ-YY7OCZY9F3fIC9Ch6cNw7wuuWAfKnGPgPV8MD-mHawPkBewtgzxT9VZ3PoTjvZ7OmFdnmLh1-rqb60y6sc3hfaewtUM9ySaDisuLux2jE3WjLQ5IJkFPrx115xrR7u_aSzOnMkqQuZ7PanWLLNo23rfUpXonHvyJRzjkEk18kNJsAcQ7ror6V1PQzh5lK6tq37WKHYwtt-_T1dqNYI1stZcZW1s0raXdKCDu-SO7X5Qnc87O6RNVveJ7c-1wSNB-Q3oI969NGqoIg-uow-WqOPViV16KMN-iggh3boozX63lFNO-xRjz1Xtoc9bKzDHu2wRz32HpJve-8Pdz8Ede6PwMQyWgQZ5hUosixj3ORM6zQ1OgddyoyEYXloQfWyMZgeQtgoyWVqpWBcZFGWSWFjFvJHZKOsSvuEUC1tnhpuQWgWpiujE52kRsaJiKWNs2hA3jRSUKc-xIsC0xjlpcxYobwUjxTIa0BeoJCUd1FuBwvVgQLqciUQWiAlo2snF-gJxlnrldzslYRR3fRuvwIgqGMzURgAHn-_V-p4psDM_QjdE-FIhMmAvGyAorACJEyWFj40xRkunaSMyQF57IHTvlwccg6GGTwte5BqC2CL_TvlZOxCz0cMAwSG7Om13_MZuY3_oF-13CQbi9mZfU5umvPFZD7bIuviSG65L-gv1t0BtQ |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+meal+replacements+therapy+on+blood+pressure+and+C-reactive+protein%3A+a+systematic+review+and+meta-analysis+of+randomized+controlled+trials&rft.jtitle=Clinical+hypertension&rft.au=Fotros%2C+Danial&rft.au=Rohani%2C+Pejman&rft.au=Prabahar%2C+Kousalya&rft.au=Fatahi%2C+Somaye&rft.date=2025&rft.pub=Korean+Society+of+Hypertension&rft.issn=2056-5909&rft.eissn=2056-5909&rft.volume=31&rft_id=info:doi/10.5646%2Fch.2025.31.e17&rft.externalDocID=A863335733 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2056-5909&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2056-5909&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2056-5909&client=summon |